View in EDS

NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2+ subtype-like characteristics in estrogen receptor-positive breast cancer cells.

Saved in:
Bibliographic Details
Title: NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2+ subtype-like characteristics in estrogen receptor-positive breast cancer cells.
Authors: Lee CH; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lin YC; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Chang YC; TMU Research Center of Cancer Translational Medicine and Taipei Cancer Center, Taipei Medical University Hospital, College of Medicine, Taipei Medical University, Taipei, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Chen PC; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Lin KH; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Yeh TM; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan., Leung EY; Auckland Cancer Society Research Centre and Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand., Lin IL; Department of Radiology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan., Chen SH; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan., Cheung CHA; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Source: Journal of Cancer [J Cancer] 2025 Feb 11; Vol. 16 (5), pp. 1694-1708. Date of Electronic Publication: 2025 Feb 11 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101535920 Publication Model: eCollection Cited Medium: Print ISSN: 1837-9664 (Print) Linking ISSN: 18379664 NLM ISO Abbreviation: J Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39991577
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2<superscript>+</superscript> subtype-like characteristics in estrogen receptor-positive breast cancer cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+CH%22">Lee CH</searchLink>; Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+YC%22">Lin YC</searchLink>; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+YC%22">Chang YC</searchLink>; TMU Research Center of Cancer Translational Medicine and Taipei Cancer Center, Taipei Medical University Hospital, College of Medicine, Taipei Medical University, Taipei, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+PC%22">Chen PC</searchLink>; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+KH%22">Lin KH</searchLink>; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Yeh+TM%22">Yeh TM</searchLink>; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Leung+EY%22">Leung EY</searchLink>; Auckland Cancer Society Research Centre and Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.<br /><searchLink fieldCode="AU" term="%22Lin+IL%22">Lin IL</searchLink>; Department of Radiology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chen+SH%22">Chen SH</searchLink>; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Cheung+CHA%22">Cheung CHA</searchLink>; Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.; Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101535920%22">Journal of Cancer</searchLink> [J Cancer] 2025 Feb 11; Vol. 16 (5), pp. 1694-1708. <i>Date of Electronic Publication: </i>2025 Feb 11 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101535920 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1837-9664 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218379664%22">18379664 </searchLink><i>NLM ISO Abbreviation: </i>J Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39991577
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.7150/jca.105425
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1694
    Titles:
      – TitleFull: NUPR1 contributes to endocrine therapy resistance by modulating BIRC5 expression and inducing luminal B-ERBB2+ subtype-like characteristics in estrogen receptor-positive breast cancer cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee CH
      – PersonEntity:
          Name:
            NameFull: Lin YC
      – PersonEntity:
          Name:
            NameFull: Chang YC
      – PersonEntity:
          Name:
            NameFull: Chen PC
      – PersonEntity:
          Name:
            NameFull: Lin KH
      – PersonEntity:
          Name:
            NameFull: Yeh TM
      – PersonEntity:
          Name:
            NameFull: Leung EY
      – PersonEntity:
          Name:
            NameFull: Lin IL
      – PersonEntity:
          Name:
            NameFull: Chen SH
      – PersonEntity:
          Name:
            NameFull: Cheung CHA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 02
              Text: 2025 Feb 11
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1837-9664
          Numbering:
            – Type: volume
              Value: 16
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Journal of Cancer
              Type: main
ResultId 1